Curing metastases with stereotactic body ablative radiotherapy (SABR)
“With longer follow-up, the magnitude of benefit of SABR was more than in the original report and durable beyond five years.” In patients who developed a few metastases, it is still possible to eradicate these tumours. This is especially if the primary cancer is under control with effective agents and the overall pace of the […]